| 1 | Vascular calcifications as a marker of increased cardiovascu… (10.2147/vhrm.s4822) | Abstract References ORCID License | 259.88 | 396 |
| 2 | Role of urate, xanthine oxidase and the effects of allopurin… (10.2147/vhrm.s4265) | Abstract References ORCID License | 225.53 | 179 |
| 3 | Platelet function tests: a comparative review (10.2147/vhrm.s44469) | Abstract References ORCID | 196.51 | 416 |
| 4 | Alpha-glucosidase inhibitors in the early treatment of type… (10.2147/vhrm.s3119) | Abstract References ORCID | 184.34 | 286 |
| 5 | Strokes in young adults: epidemiology and prevention (10.2147/vhrm.s53203) | Abstract References ORCID | 182.71 | 272 |
| 6 | Potential of liraglutide in the treatment of patients with t… (10.2147/vhrm.s4039) | Abstract References ORCID License | 182.61 | 66 |
| 7 | The management of gestational diabetes (10.2147/vhrm.s3405) | Abstract References ORCID License | 181.29 | 64 |
| 8 | Triglyceride-rich lipoproteins as a causal factor for cardio… (10.2147/vhrm.s104369) | Abstract References ORCID | 173.22 | 203 |
| 9 | Vascular risk factors, cognitve decline, and dementia (10.2147/vhrm.s1839) | Abstract References ORCID | 173.06 | 202 |
| 10 | Fibrosis in diabetes complications: Pathogenic mechanisms an… (10.2147/vhrm.s1991) | Abstract References ORCID | 171.75 | 194 |
| 11 | The influence of perivascular adipose tissue on vascular hom… (10.2147/vhrm.s33760) | Abstract References ORCID | 166.90 | 167 |
| 12 | Cerebral blood flow in Alzheimer’s disease (10.2147/vhrm.s34874) | Abstract References ORCID | 166.90 | 167 |
| 13 | Expert review on coronary calcium (10.2147/vhrm.s1160) | Abstract References ORCID | 166.70 | 166 |
| 14 | Review of tenecteplase (TNKase) in the treatment of acute my… (10.2147/vhrm.s3848) | Abstract References ORCID License | 165.32 | 44 |
| 15 | The renin–angiotensin system and diabetes: An upda… (10.2147/vhrm.s1905) | Abstract References ORCID | 165.31 | 159 |
| 16 | Critical limb ischemia: current challenges and future prospe… (10.2147/vhrm.s125065) | Abstract References ORCID | 165.10 | 158 |
| 17 | Perioperative hypertension management (10.2147/vhrm.s2471) | Abstract References ORCID | 163.64 | 151 |
| 18 | Ankle Brachial Pressure Index (ABPI): An update for practiti… (10.2147/vhrm.s6759) | Abstract References ORCID | 163.42 | 150 |
| 19 | Early vascular aging (EVA): consequences and prevention (10.2147/vhrm.s1094) | Abstract References ORCID | 163.21 | 149 |
| 20 | Diabetic cardiomyopathy: from the pathophysiology of the car… (10.2147/vhrm.s11681) | Abstract References ORCID | 162.99 | 148 |
| 21 | Redefining the role of thiazolidinediones in the management… (10.2147/vhrm.s4664) | Abstract References ORCID License | 161.28 | 40 |
| 22 | Beta-glucans in the treatment of diabetes and associated car… (10.2147/vhrm.s3803) | Abstract References ORCID | 160.25 | 136 |
| 23 | Feasibility and effectiveness of a disease and care manageme… (10.2147/vhrm.s9252) | Abstract References ORCID | 160.02 | 135 |
| 24 | Natriuretic peptides (BNP and NT-proBNP): measurement and re… (10.2147/vhrm.s5789) | Abstract References ORCID | 158.80 | 130 |
| 25 | Emerging role of dipeptidyl peptidase-4 inhibitors in the ma… (10.2147/vhrm.s1707) | Abstract References ORCID | 158.55 | 129 |
| 26 | The effects of fatigue, pain, and depression on quality of l… (10.2147/vhrm.s32780) | Abstract References ORCID | 157.79 | 126 |
| 27 | Avoiding hypoglycemia: a key to success for glucose-lowering… (10.2147/vhrm.s33934) | Abstract References ORCID | 156.74 | 122 |
| 28 | TNF-α-mediated inflammation in cerebral aneurysms:… (10.2147/vhrm.s2700) | Abstract References ORCID | 156.48 | 121 |
| 29 | Peroxisome proliferator-activated receptor-γ agoni… (10.2147/vhrm.s993) | Abstract References ORCID | 156.21 | 120 |
| 30 | Matrix metalloproteinases in atherosclerosis: role of nitric… (10.2147/vhrm.s68415) | Abstract References ORCID | 155.39 | 117 |
| 31 | Comparison of bioavailability of krill oil versus fish oil a… (10.2147/vhrm.s85165) | Abstract References ORCID | 155.11 | 116 |
| 32 | Pre-eclampsia: pathophysiology, diagnosis, and management (10.2147/vhrm.s20181) | Abstract References ORCID | 152.20 | 106 |
| 33 | Troponin elevation in conditions other than acute coronary s… (10.2147/vhrm.s24509) | Abstract References ORCID | 152.20 | 106 |
| 34 | Guar gum and similar soluble fibers in the regulation of cho… (10.2147/vhrm.s3512) | Abstract References ORCID | 152.20 | 106 |
| 35 | The importance of endothelin-1 for microvascular dysfunction… (10.2147/vhrm.s3920) | Abstract References ORCID | 151.59 | 104 |
| 36 | Characterizing blood microparticles: Technical aspects and c… (10.2147/vhrm.s955) | Abstract References ORCID | 151.59 | 104 |
| 37 | Weight neutrality with the DPP-4 inhibitor, vildagliptin: Me… (10.2147/vhrm.s10952) | Abstract References ORCID | 148.33 | 94 |
| 38 | Effect of angiotensin receptor blockade on endothelial funct… (10.2147/vhrm.s3141) | Abstract References ORCID License | 147.71 | 29 |
| 39 | Clinical efficacy and safety of statins in managing cardiova… (10.2147/vhrm.s1653) | Abstract References ORCID | 147.64 | 92 |
| 40 | Habitual coffee consumption and blood pressure: An epidemiol… (10.2147/vhrm.s3055) | Abstract References ORCID | 146.93 | 90 |
| 41 | Mechanisms of endothelial dysfunction in obstructive sleep a… (10.2147/vhrm.s4078) | Abstract References ORCID | 146.93 | 90 |
| 42 | Ezetimibe therapy: mechanism of action and clinical update (10.2147/vhrm.s33664) | Abstract References ORCID | 146.57 | 89 |
| 43 | Efficacy and safety of rosuvastatin in the management of dys… (10.2147/vhrm.s3662) | Abstract References ORCID License | 146.24 | 28 |
| 44 | Cardiovascular co-morbidity in rheumatic diseases (10.2147/vhrm.s2453) | Abstract References ORCID | 146.20 | 88 |
| 45 | Arterial stiffness, central hemodynamics, and cardiovascular… (10.2147/vhrm.s25270) | Abstract References ORCID | 144.32 | 83 |
| 46 | Thrombosis in the critically ill neonate: incidence, diagnos… (10.2147/vhrm.s4274) | Abstract References ORCID | 143.93 | 82 |
| 47 | Steady-state bioavailability of prescription omega-3 on a lo… (10.2147/vhrm.s50464) | Abstract References ORCID | 143.54 | 81 |
| 48 | Secondary stroke prevention: challenges and solutions (10.2147/vhrm.s63791) | Abstract References ORCID | 143.54 | 81 |
| 49 | Anxiety and depression in patients with pulmonary hypertensi… (10.2147/vhrm.s147173) | Abstract References ORCID | 143.14 | 80 |
| 50 | Glimepiride: evidence-based facts, trends, and observations (10.2147/vhrm.s33194) | Abstract References ORCID | 143.14 | 80 |